Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia
Ashok K. Shetty
Aging and Disease (2020) Vol. 11, Iss. 2, pp. 462-462
Open Access | Times Cited: 129

Showing 1-25 of 129 citing articles:

Challenges and advances in clinical applications of mesenchymal stromal cells
Tian Zhou, Zenan Yuan, Jianyu Weng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 450
Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19
Loubna Mazini, Mohamed Ezzoubi, Gabriel Malka
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 175
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna Patel, Kishu Ranjan
Biomolecules (2021) Vol. 11, Iss. 7, pp. 993-993
Open Access | Times Cited: 166
Potential therapeutic options for COVID-19: an update on current evidence
Zahra Niknam, Ameneh Jafari, Ali Golchin, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 139
Precision drug delivery to the central nervous system using engineered nanoparticles
Jingjing Gao, Ziting Xia, Swetharajan Gunasekar, et al.
Nature Reviews Materials (2024) Vol. 9, Iss. 8, pp. 567-588
Closed Access | Times Cited: 24
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
Christopher J. Rogers, Robert J. Harman, Bruce A. Bunnell, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 107
Mesenchymal stem cells: current clinical progress in ARDS and COVID-19
Kun Xiao, Fei Hou, Xiuyu Huang, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 85
Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia
Pietro Gentile, Aris Sterodimas
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 7, pp. 711-716
Open Access | Times Cited: 79
Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises
Arefeh Basiri, Zahra Pazhouhnia, Nima Beheshtizadeh, et al.
Stem Cell Reviews and Reports (2020) Vol. 17, Iss. 1, pp. 163-175
Open Access | Times Cited: 79
Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Francesca Rossi, Chiara Tortora, Maura Argenziano, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3809-3809
Open Access | Times Cited: 77
Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises
Leila Rezakhani, Ali Fatahian Kelishadrokhi, Arghavan Soleimanizadeh, et al.
Chemistry and Physics of Lipids (2020) Vol. 234, pp. 105009-105009
Open Access | Times Cited: 74
The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm
Maria Kavianpour, Mahshid Saleh, Javad Verdi
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 70
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19
Michael E. Bowdish, Christina E. Barkauskas, Jessica Overbey, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 207, Iss. 3, pp. 261-270
Open Access | Times Cited: 43
A Perspective on Emerging Therapeutic Interventions for COVID-19
Muhammad Torequl Islam, Md. Nasiruddin, Ishaq Khan, et al.
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 64
Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm
Na Song, Hiroaki Wakimoto, Filippo Rossignoli, et al.
Stem Cells (2021) Vol. 39, Iss. 6, pp. 707-722
Open Access | Times Cited: 55
Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis
Iago Carvalho Schultz, Ana Paula Santin Bertoni, Márcia Rosângela Wink
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 2, pp. 341-356
Open Access | Times Cited: 54
The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients
Faisal A. Alzahrani, Islam M. Saadeldin, Abrar Ahmad, et al.
Stem Cells International (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 53
Dynamics of the COVID-19 Contagion and Mortality: Country Factors, Social Media, and Market Response Evidence From a Global Panel Analysis
Piotr Staszkiewicz, Iwona Chomiak-Orsa, Igor Staszkiewicz
IEEE Access (2020) Vol. 8, pp. 106009-106022
Open Access | Times Cited: 51
Mesenchymal stem cells for restoring endometrial function: An infertility perspective
Ruttachuk Rungsiwiwut, Pramuan Virutamasen, Kamthorn Pruksananonda
Reproductive Medicine and Biology (2020) Vol. 20, Iss. 1, pp. 13-19
Open Access | Times Cited: 50
Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment
Arefeh Basiri, Fatemeh Mansouri, Arezo Azari, et al.
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 1, pp. 193-213
Open Access | Times Cited: 45
2021 Acute Respiratory Distress Syndrome Update, With Coronavirus Disease 2019 Focus
Carson Welker, Jeffrey Huang, Iván J. Núñez‐Gil, et al.
Journal of Cardiothoracic and Vascular Anesthesia (2021) Vol. 36, Iss. 4, pp. 1188-1195
Open Access | Times Cited: 45
Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Acquire Rejuvenation and Reduced Heterogeneity
Wasco Wruck, Nina Graffmann, Lucas‐Sebastian Spitzhorn, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 42
Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
Firas El Chaer, Jeffery J. Auletta, Roy F. Chemaly
Blood (2022) Vol. 140, Iss. 7, pp. 673-684
Open Access | Times Cited: 28
Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives.
Shahrzad Najafi, Parizad Najafi, Najmeh Kaffash Farkhad, et al.
PubMed (2023) Vol. 26, Iss. 8, pp. 872-881
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top